Skip to main content
PBSV logo

PBSV

Pharma-Bio Serv, Inc.
$0.57 +0.00 (+0.00%) At close · Jul 2
Market Cap
$13.05M
Shares
22,901,692

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.57 Open$0.57 Day$0.57–0.57 52W$0.40–1.19 Avg vol 30d387 Short int404 · 0.0% float · 1.0d Short vol40% Last earningsJun 15, 2026 DataJan 2020–Jul 2026 Filing10-Q · Jun 15
Equibles Rating blended score · not investment advice
Overall
Buy
Technical · trend & momentum Buy
50 / 200-day cross no cross
+ Price vs 200-day avg +3% above
+ Price vs 50-day avg +5% above
RSI (14) 59 · neutral
+ MACD trend positive
52-week position 21% · mid-range
Sentiment · smart money Bearish
Trend (MA cross) 50d $1 › 200d $1 — 200d above 50d
Institutional flow No 13F holder data
Insider flow No net insider activity over 90 days
Short interest 0.00% of float · 1.0 days cover
Volume signal Volume near normal
Institution breadth No 13F holder history
Fundamentals Fair
Revenue growth −5% Y/Y
+ Gross margin 32%, expanding
+ EPS growth +88% Y/Y
Free cash flow $-221.5K
Valuation P/E 190 · rich
+ Buyback $518.7K authorized
+ Balance sheet net cash $14.5M

Blended from price, positioning & fundamentals · daily-close · not investment advice.

Up next
Next earnings call
Sep 14, 2026 Est · unconfirmed · in 10 wks
FQ3-26 quarter ends
~Jul 31, 2026 Est
filed Jun 15, 2026

Technicals

trend & momentum for long-term holders Buy
0 · 3 · 3
50 / 200-day cross
no cross Neutral
Price vs 200-day avg
+3% above Bullish
Price vs 50-day avg
+5% above Bullish
RSI (14)
59 · neutral Neutral
MACD trend
positive Bullish
52-week position
21% · mid-range Neutral
Market signals — smart money & positioning
Bearish · 1 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.00% of float · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
52-wk low $0 Now $1 · 21% 52-wk high $1
vs 200-day avg +3% vs 50-day avg +5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Health Information Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
PBSV
Pharma-Bio Serv, Inc.
this stock
$13.05M +8.8% -5.3% 190.0 0.0%
VEEV
Veeva Systems Inc
$31.31B -13.7% +28.1% 34.2 4.6%
PMDIY
Pro Medicus Ltd./ADR
$15.67B -9.4% 0.0%
BTSG
BrightSpring Health Services, Inc.
$13.39B +84.3% -0.4% 49.3 4.8%
TEM
Tempus AI, Inc.
$11.14B +2.1% +65.8% 21.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Rising
Shares short
404
Days to cover
1.0d
Change
+404 sh
View
Short Volume
Short vol %
40%
As of
Jun 15, 2026
Short Total
View
Off-Exchange
Off-exchange %
100.0%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$9.0M
Net income (FY)
$-100.5K
EPS diluted
$0.00
View
Buybacks
Authorized
$518.7K
View
Filings
SEC Filings
Latest
8-K
Filed
Jun 15, 2026
This year
9
View
Earnings & Events
Earnings Calls
Last call
Jun 15, 2026
View

Performance

5D 20D 120D MTD YTD
PBSV +0.0% +0.0% +20.9% +0.0% +8.8%
SPY +1.4% -1.3% +8.0% -0.3% +9.2%
vs SPY -1.4% +1.3% +12.9% +0.3% -0.4%

Capital returns

Latest dividend
$0.075 / share · ex Feb 27, 2026
Paid (TTM)
$0.075 / share · 1 payout
Dividend yield (TTM, derived)
· history filling in
Buyback program · as of Apr 30, 2026
Authorized
$518,704
Spent (derived)
Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1304161 Visit website